CGEM vs MS · $830.3M cap vs P/E 20, $344.27B cap
Cullinan Oncology LLC (CGEM) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
MS does not have a complete income-statement cache yet.
CGEM currently screens at market cap $830.3M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CGEM and MS stock pages for the full models.
Not investment advice.